Procalcitonin to reduce antimicrobial overuse in patients with lower respiratory tract infection: time for re-evaluation of our prescription culture?

Affiliations

¹ Section of Respiratory Medicine, Department of Medicine, Herlev-Gentofte Hospital, Herlev, Denmark.
² Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen DK-2100, Denmark. Electronic address: jens.ulrik.jensen@regionh.dk.

Comment

Pradeesh Sivapalan et al. Lancet Infect Dis. 2023 Apr.

. 2023 Apr;23(4):390-391.

doi: 10.1016/S1473-3099(22)00757-5. Epub 2022 Dec 13.

¹ Section of Respiratory Medicine, Department of Medicine, Herlev-Gentofte Hospital, Herlev, Denmark.
² Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen DK-2100, Denmark. Electronic address: jens.ulrik.jensen@regionh.dk.

No abstract available

Conflict of interest statement

We declare no competing interests.

Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial.
Tsalik EL, Rouphael NG, Sadikot RT, Rodriguez-Barradas MC, McClain MT, Wilkins DM, Woods CW, Swamy GK, Walter EB, El Sahly HM, Keitel WA, Mulligan MJ, Tuyishimire B, Serti E, Hamasaki T, Evans SR, Ghazaryan V, Lee MS, Lautenbach E; TRAP-LRTI Study Group; Antibacterial Resistance Leadership Group. Tsalik EL, et al. Lancet Infect Dis. 2023 Apr;23(4):484-495. doi: 10.1016/S1473-3099(22)00735-6. Epub 2022 Dec 13. Lancet Infect Dis. 2023. PMID: 36525985 Free PMC article. Clinical Trial.